bicalutamide and tanshinone

bicalutamide has been researched along with tanshinone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jeong, SJ; Jiang, C; Kim, SH; Lee, EO; Lee, HJ; Lü, J; Won, SH; Ye, M; Zhang, J; Zhang, Y	1

Other Studies

1 other study(ies) available for bicalutamide and tanshinone

Article	Year
Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling. Pharmaceutical research, 2012, Volume: 29, Issue:6 Topics: Abietanes; Active Transport, Cell Nucleus; Androgen Antagonists; Anilides; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Phenanthrenes; Prostate-Specific Antigen; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Receptors, Androgen; RNA, Messenger; Salvia miltiorrhiza; Signal Transduction; Time Factors; Tosyl Compounds; Tumor Burden; Xenograft Model Antitumor Assays	2012

Article

Year

Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.

Pharmaceutical research, 2012, Volume: 29, Issue:6

Topics: Abietanes; Active Transport, Cell Nucleus; Androgen Antagonists; Anilides; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Phenanthrenes; Prostate-Specific Antigen; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Receptors, Androgen; RNA, Messenger; Salvia miltiorrhiza; Signal Transduction; Time Factors; Tosyl Compounds; Tumor Burden; Xenograft Model Antitumor Assays

2012